Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists map immune cells in rare cancer to boost immunotherapy

NCT ID NCT07561190

First seen May 07, 2026 · Last updated May 25, 2026 · Updated 3 times

Summary

This study looks at the immune system inside malignant pleural mesothelioma tumors. Researchers want to understand why immunotherapy doesn't work for many patients. They will analyze tumor samples from 300 adults to find patterns that could help doctors choose better treatments in the future. This is an observational study, not a test of a new drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA (MPM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Azienda Ospedaliera Universitaria Luigi Vanvitelli, Napoli

    RECRUITING

    Naples, Italy

    Contact Email: •••••@•••••

  • Azienda Ospedaliera Universitaria Policlinico Rodolico San Marco di Catania

    RECRUITING

    Catania, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Azienda USL IRCCS di Reggio Emilia

    RECRUITING

    Reggio Emilia, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.